Condition (MeSH)
Hand Deformities
ClinicalTrials.gov lists 11 trials for Hand Deformities or a narrower condition beneath it. Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E. has the most among industry and government lead sponsors, with 1.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
7 of the 11 trials are tagged with Hand Deformities itself; the rest are tagged with a narrower condition beneath it.
When did Hand Deformities trials start? (8)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 4
- Not applicable
- Observational
Top of scale: 2
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2024 | 1 |
| 2023 | 2 |
| 2022 | 2 |
| 2021 | 1 |
| 2018 | 1 |
| 2014 | 1 |
| 2004 | 2 |
No forecast is made for this condition: it averages 1.2 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Hand Deformities trials in? (4)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 1 |
| Phase 4 | 1 |
| Not applicable | 7 |
| Observational | 2 |
How many Hand Deformities trials are recruiting? (3)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 1 |
| Completed | 7 |
| Unknown status | 3 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Hand Deformities trials? (1)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E. | 1 |
Interventions as named in the registry (1)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Catapresan | 1 |
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which publications cover Hand Deformities? (10)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| The incidence and spectrum of congenital hand differences in patients with Fanconi anaemia: analysis of 48 patients. | The Journal of hand surgery, European volume | 2022 | Yes |
| Ring orthosis design and production by rapid prototyping approach. | Journal of hand therapy : official journal of the American Society of Hand Therapists | 2020 | Yes |
| The Neurological Hand Deformity Classification for children with cerebral palsy. | Australian occupational therapy journal | 2014 | Yes |
| Reconstruction of the hand with wide awake surgery. | Clinics in plastic surgery | 2011 | Yes |
| Loss of dermatan-4-sulfotransferase 1 function results in adducted thumb-clubfoot syndrome. | American journal of human genetics | 2009 | Yes |
Showing 5 of 10 publications.
Sub-conditions in MeSH (1)
MeSH descendants one level down with at least one trial, most trials first.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, and rare-disease identity.